Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0,16%
1 095,57
+1,76
+0,16%
—1 093,811 096,521 100,221 093,20——
SIXC
Communications
SIXC
Communications
SIXC
+0,31%
610,68
+1,91
+0,31%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,05%
1 241,69
-13,12
-1,05%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,64%
1 749,84
-11,27
-0,64%
—1 761,111 764,271 766,881 745,39——
SIXM
Financials
SIXM
Financials
SIXM
-0,10%
641,96
-0,62
-0,10%
—642,58644,87648,48641,40——
SIXR
Staples
SIXR
Staples
SIXR
-0,21%
849,34
-1,79
-0,21%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,24%
217,46
-0,52
-0,24%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,61%
3 263,55
+51,72
+1,61%
—3 211,833 227,213 267,763 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,47%
944,49
-4,49
-0,47%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,26%
1 470,67
-3,85
-0,26%
—1 474,521 479,031 481,041 469,17——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,62%
2 406,89
+14,77
+0,62%
—2 392,122 396,952 421,222 382,32——
PTGX:NASDAQ
Protagonist Therapeutics Inc
USD 98,27
-0,71%
(-0,70) 1D
1 Mei, 15:31:33 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PTGX...
Open
USD 99,16
High
USD 99,46
Low
USD 97,08
Mkt. cap
6,34 mjd
Avg. vol.
893,94 k
Volume
140,10 k
52-wk high
USD 107,84
52-wk low
USD 41,28
EPS
-USD 2,05
Beta
2,12
Shares outstanding
63,81 m
No. of employees
132
News stories
From sources across the web
About Protagonist Therapeutics Inc
CEO-
Employees132
Founded2006
HeadquartersNewark, Kalifornië, Verenigde State van Amerika
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
28,32 m
5,55 m
4,71 m
7,44 m
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
35,89 m
37,04 m
40,00 m
46,36 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,74 m
10,55 m
11,13 m
11,43 m
Operating expense
47,63 m
47,59 m
51,13 m
57,79 m
Total operating expenses
47,63 m
47,59 m
51,13 m
57,79 m
Operating income
-19,31 m
-42,04 m
-46,42 m
-50,36 m
Other non operating income
-
-
-
27,00 k
EBT including unusual items
-11,66 m
-34,60 m
-39,34 m
-43,72 m
EBT excluding unusual items
-11,66 m
-34,60 m
-39,34 m
-43,72 m
Income tax expense
-
172,00 k
-
666,00 k
Effective tax rate
-
-0,50%
-
-1,52%
Other operating expenses
-
-
-
-
Net income
-11,66 m
-34,77 m
-39,34 m
-44,38 m
Net profit margin
-41,15%
-626,96%
-834,87%
-596,80%
Earnings per share
-0,19
-0,55
-0,62
-0,69
Interest and investment income
7,57 m
7,41 m
7,05 m
6,76 m
Interest expense
-
-
-
-
Net interest expenses
7,57 m
7,41 m
7,05 m
6,76 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-19,07 m
-41,74 m
-46,06 m
-49,98 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more